Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Reason 27 not to sell out to Big Pharma.

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Dec 21, 2022 10:45am

257 Views

Post# 35184551

RE:RE:RE:RE:Reason 27 not to sell out to Big Pharma.

So says the "medical director" of unknown background who became a Stockhouse member 15min ago. Rather than sell immediately based on this synopsis. I'm probably going to listen to the actual Urologists, PhD Scientists, and real Doctors who say it will work my friend. Thanks for coming out though. Really.

<< Previous

Bullboard Posts

Next >>

Ivanhoe Mines initiates Phase 3 concentrator construction